Measuring individual parathyroid gland hormone production in real-time during radioguided parathyroidectomy. Experience in over 8 000 operations

Minerva Endocrinologica

Volumn 33, Issue 3, 2008, Pages 147-157

  Norman, J ^a   Politz, D ^a  

^a Norman Parathyroid Clinic   (United States)

Author keywords

Hyperparathyroidism; Parathyroid diseases; Parathyroid hormone

Indexed keywords

FAT; PARATHYROID HORMONE; CALCIUM; DIAGNOSTIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PTH PROTEIN, HUMAN; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; EX VIVO STUDY; FEMALE; HORMONE SYNTHESIS; HUMAN; HUMAN TISSUE; HYPERPARATHYROIDISM; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; PARATHYROID ADENOMA; PARATHYROID GLAND; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HYPERPLASIA; PARATHYROID SCINTISCANNING; PARATHYROIDECTOMY; PRESCHOOL CHILD; RADIATION DETECTION; RADIOACTIVITY; RADIOSURGERY; REAL TIME ECHOGRAPHY; SCHOOL CHILD; SURGEON; THYMUS; THYROID NODULE; TISSUE TYPES; ADENOMA; ADIPOSE TISSUE; BIOSYNTHESIS; BLOOD; COMPUTER ASSISTED SURGERY; COMPUTER SYSTEM; HYPERTROPHY; INTRAOPERATIVE PERIOD; METHODOLOGY; MIDDLE AGED; PARATHYROID TUMOR; PATHOLOGY; PROSPECTIVE STUDY; RADIOGRAPHY; SCINTISCANNING; SECRETION;

ADENOMA; ADIPOSE TISSUE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CALCIUM; CHILD; COMPUTER SYSTEMS; FEMALE; HUMANS; HYPERTROPHY; INTRAOPERATIVE PERIOD; LYMPH NODES; MALE; MIDDLE AGED; PARATHYROID GLANDS; PARATHYROID HORMONE; PARATHYROID NEOPLASMS; PARATHYROIDECTOMY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SURGERY, COMPUTER-ASSISTED; TECHNETIUM TC 99M SESTAMIBI; THYROID NODULE;

EID: 58149392645     PISSN: 03911977     EISSN: 18271634     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Norman J, Cheda H. Minimally invasive parathyroidectomy facilitated by intraoperative nuclear mapping. Surgery 1997;122:998-1004. (Pubitemid 28016665)
2. Norman J. The technique of intraoperative nuclear mapping to facilitate minimally invasive parathyroidectomy. Cancer Control 1997;4:500-4. (Pubitemid 28167816)
3. Norman J, Cheda H, Farrell C. Minimally invasive parathyroidectomy for primary hyperparathyroidism: decreasing operative time and potential complications while improving cosmetic results. Am Surg 1998;64:391-6.
4. Costello D, Norman J. Minimally invasive radio-guided parathyroidectomy (MIRP). Surg Clin North Am 1999;8:555-64. (Pubitemid 29321222)
5. Murphy C, Norman J. The 20 percent rule: a simple instantaneous radioactivity measurement defines cure and allows elimination of frozen section and hormone assays during parathyroidectomy. Surgery 1999;126:1023-9.
6. Flynn MB, Bumpous JM, Schill K, McMasters KM. Minimally invasive radioguided parathyroidectomy. J Am Coll Surg 2000;191:24-31
7. Goldstein RE, Blevins L, Delbeke D, Martin WH. Effect of minimally invasive radioguided parathyroidectomy on efficacy, length of stay, and costs in the management of primary hyperparathyroidism. Ann Surg 2000;231:732-42.
8. Lee WJ, Ruda J, Stack BC. Minimally invasive radioguided parathyroidectomy (MIRP) using intraoperative sestamibi localization. Otolaryngol Clin North Am 2004;37:789-98.
9. Rubello D, Piotto A, Medi F, Gross MD, Shapiro B, Erba P et al.; Italian Study Group on Radioguided Surgery and ImmunoScintigraphy. 'Low dose' 99mTc-Sestamibi for radioguided surgery of primary hyperparathyroidism. Eur J Surg Oncol 2005;31:191-6.
10. Grady JA, Bumpous JM, Fleming MM, Flynn MB, Turbiner E, Lentsch EJ et al. Advantages of a targeted approach in minimally invasive radioguided parathyroidectomy surgery for primary hyperparathyroidism. Laryngoscope 2006;116:431-5.
11. Rubello D, Giannini S, Martini C, Piotto A, Rampin L, Fanti S et al. Minimally invasive radio-guided parathyroidectomy. Biomed Pharmacother 2006;60:134-8.
12. Ruda JM, Hollenbeak CS, Stack BC, A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 2005;132:359-72.
13. Mitchell BK, Merrell RC, Kinder BK. Localization studies in patients with hyperparathyroidism. Surg Clin North Am 1995;75:483-98. Review.
14. Calva-Cerqueira D, Smith BJ, Hostetler ML, Lal G, Menda Y, O'Dorisio TM et al. Minimally invasive parathyroidectomy and preoperative MIBI scans: correlation of gland weight and preoperative PTH. J Am Coll Surg 2007;205(4 Suppl):S38-44.
15. Norman J, Rubello D, Giuliano A, Mariani, G. Minimally invasive radioguided parathyroidectomy in primary hyperparathyroidism. In: Mariani G, Strauss HW, Guiliano A, editors. Radioguided surgery: A Comprehensive Team Approach, p 226-32. New York: Springer Verlag; 2008.
16. Norman J, Denham D. Minimally invasive radioguided parathyroidectomy in the reoperative neck. Surgery 1998;124:1088-93.
17. Ugur O, Kara PO, Bozkurt MF, Hamaloglu E, Tezel GG, Salanci BV et al. In vivo characterization of parathyroid lesions by use of gamma probe: comparison with ex vivo count method and frozen section results. Otolaryngol Head Neck Surg 2006:134;316-20.
18. Norman J. Method and kit for locating hyperactive parathyroid tissue or adenomatous tissue in a patient and for removal of such tissue. 2001. US Patent # 6,263,232.
19. Politz D, Norman J. Hyperparathyroidism in patients over 80: Clinical characteristics and their ability to undergo outpatient parathyroidectomy. Thyroid 2007;17:333-9.
20. Denham D, Norman J. Cost-effectiveness of preoperative sestamibi scan for primary hyperparathyroidism is dependent solely upon surgeon's choice of operative procedure. J Am Coll Surg 1998;186:293-304.
21. Chheda H, Norman J. Methodology for quick, high-resolution sestamibi scanning to localize parathyroid adenomas. [1998, updated 2007]. Available at: http://www.parathyroid.com/sestamibi.htm
22. Norman J, Aronson K. Outpatient parathyroid surgery in the morbidly obese patient. Otolaryngology Head Neck Surg 2004:131;133-9.
23. Norman J, Politz D. Safety of immediate discharge following parathyroidectomy: A prospective study in 3000 consecutive patients. Endocr Pract 2007;13:105-13.
24. You CJ, Zapas JL. Diminished dose minirnally invasive radioguided parathyroidectomy: a case for radioguidance. Am Surg 2007;73:669-72; discussion 673.
25. Lal A, Bianco J, Chen H. Radioguided parathyroidectomy in patients with familial hyperparathyroidism. Ann Surg Oncol 2007;14:739-43.
26. Grady JA, Bumpous JM, Fleming MM, Flynn MB, Turbiner E, Lentsch EJ et al. Advantages of a targeted approach in minimally invasive radioguided parathyroidectomy surgery for primary hyperparathyroidism. Laryngoscope 2006;116:431-5
27. Rubello D, Giannini S, Martini C, Piotto A, Rampin L, Fanti S et al. Minimally invasive radio-guided parathyroidectomy. Biomed Pharmacother 2006;60:134-8.
28. Hutchinson JR, Yandell DW, Bumpous JM, Fleming MM, Flynn MB. Three-year financial analysis of minimally invasive radio-guided parathyroidectomy. Am Surg 2004;70:1112-5.
29. Rubello D, Piotto A, Medi F, Gross MD, Shapiro B, Erba P et al.; Italian Study Group on Radioguided Surgery and ImmunoScintigraphy. "Low dose" 99mTc-sestamibi for radioguided surgery of primary hyperparathyroidism. Eur J Surg Oncol 2005;31:191-6.
30. Goldstein RE, Billheimer D, Martin WH, Richards K. Sestamibi scanning and minimally invasive radioguided parathyroidectomy without intraoperative parathyroid hormone measurement. Ann Surg 2003;237:722-30; discussion 730-1.
31. Norman J, Politz D. Analysis of 18 clinical parameters during 6000 parathyroid operations to identify good candidates for unilateral parathyroidectomy. Otolaryngology Head Neck Surg 2008 [in press].
32. Carneiro-Pla DM, Romaguera R, Nadji M, Lew JI, Solorzano CC, Irvin GL 3rd. Does histopathology predict parathyroid hypersecretion and influence correctly the extent of parathyroidectomy in patients with sporadic primary hyperparathyroidism? Surgery. 2007;142:930-5; discussion 930-5.
33. Chiu B, Sturgeon C, Angelos P. Which intraoperative parathyroid hormone assay criterion best predicts operative success? A study of 352 consecutive patients. Arch Surg 2006;141:483-7.
34. Karakousis GC, Han D, Kelz RR, Nemani D, Karamacharya J, Roses R et al. Interpretation of intraoperative PTH changes in patients with multi-glandular primary hyperparathyroidism (pHPT). Surgery 2007;142:845-50.
35. Westerdahl J, Bergenfelz A. Parathyroid surgical failures with sufficient decline of intraoperative parathyroid hormone levels: unobserved multiple endocrine neoplasia as an explanation. Arch Surg 2006;141:589-94.
36. Norman J. Minimally invasive parathyroid surgery. Recent trends becoming standard of care yielding smaller, more successful operations at a lower cost. Otolaryngol Clin North Am 2004;37:683-8.
37. Solórzano CC, Carneiro-Pla DM, Lew JI, Rodgers SE, Montano R, Irvin GL 3rd. Intra-operative parathyroid hormone monitoring in patients with parathyroid cancer. Ann Surg Oncol 2007;14:3216-22.
38. Westerdahl J, Bergenfelz A. Sestamibi scan-directed parathyroid surgery: potentially high failure rate without measurement of intraoperative parathyroid hormone. World J Surg 2004;28:1132-8.
39. Norman J, Politz D. 5000 parathyroid operations without frozen section or PTH assays: Measuring individual parathyroid gland hormone production in realtime. Ann Surg Oncol 2008 [In press].